Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades.
We have attracted world-leading scientific expertise in phosphatase-driven disease biology and drug discovery to unlock the full potential of phosphatase-targeted allosteric modulators. In oncology, Anavo is developing multiple first-in-class therapeutic programs and will build on partnerships around its platform to establish a rich pipeline across several indications.
Anavo is backed by blue-chip investors M Ventures, INKEF Capital, Taiho Ventures, and Bioqube Ventures.
Location: Netherlands, South Holland, Leiden
Employees: 1-10
Total raised: $85.32M
Founded date: 2021
Investors 4
| Date | Name | Website |
| 22.04.2021 | M Ventures | m-ventures... |
| 11.05.2023 | MRL Ventur... | mrlv.com |
| 29.04.2021 | Taiho Vent... | taihoventu... |
| - | Bioqube Ve... | bioqubeven... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 05.05.2023 | - | $30.5M | - |
| 03.05.2023 | Seed | $30.7M | M Ventures |
| 22.04.2021 | Seed | $24.12M | - |
Mentions in press and media 12
| Date | Title | Description | Source |
| 05.05.2023 | Anavo Therapeutics extends Seed Round to EUR 28 Million to A... | Leiden, The Netherlands, and Heidelberg, Germany, May 2, 2023 – Anavo Therapeutics, a global leader ... | bioqubeven... |
| 03.05.2023 | Dutch-based Anavo Therapeutics secures €8.5M to systematical... | Leiden-based Anavo Therapeutics, a company that claims to be the first to systematically drug phosph... | siliconcan... |
| 02.05.2023 | Anavo Therapeutics Raises €8.5M; Extends Seed Round to €28M... | Anavo Therapeutics, a Leiden, Netherlands- and Heidelberg, Germany-based human phosphatase biology c... | finsmes.co... |
| 22.04.2021 | Anavo Therapeutics Launches with EUR 20 Million Seed Financi... | Leiden, The Netherlands, April 22, 2021 – Anavo Therapeutics, a global leader in unlocking the full ... | m-ventures... |
| 22.04.2021 | Anavo Therapeutics : Launches with EUR 20 Million Seed Finan... | Anavo Therapeutics, a global leader in unlocking the full therapeutic potential of human phosphatase... | marketscre... |
| 19.10.2018 | Anavo Technologies Announces $3.6 Million Investment by Blue... | Anavo Technologies, an intellectual property holding company that identifies and capitalizes on new ... | citybizlis... |
| - | Anavo Therapeutics | “UNLOCKING THE PHOSPHATASE TARGET CLASS: Anavo Therapeutics is the first company to systematically d... | fastfounde... |
| - | Anavo Therapeutics to Establish R&D Hub in World-Leading... | Leiden, The Netherlands, and Heidelberg, Germany, August 16, 2021 – Anavo Therapeutics, a global lea... | bioqubeven... |
| - | Anavo Therapeutics extends Seed Round to EUR 28 Million to A... | Leiden, The Netherlands, and Heidelberg, Germany, May 2, 2023 – Anavo Therapeutics, a global leader ... | bioqubeven... |
| - | Anavo Therapeutics strengthens management team | The company appoints industry veteran Shaun McNulty as Chief Scientific Officer and welcomes R&D... | bioqubeven... |
Show more